Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Ovarian Neoplasms 24 Neoplasms 10 Fallopian Tube Neoplasms 7 Breast Neoplasms 5 Prostatic Neoplasms 4 Pancreatic Neoplasms 3 Neoplasm Metastasis 2 Mesothelioma 2 Carcinoma, Transitional Cell 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Non-Small-Cell Lung 2 Uveal Melanoma 1 Uterine Neoplasms 1 Urothelial Cancer 1 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Unilateral Breast Neoplasms 1 Triple Negative Breast Neoplasms 1 Solid Tumor 1 Sarcoma, Ewing 1 Recurrence 1 Prostatic Diseases 1 Prostate Carcinoma Metastatic to the Bone 1 Prostate Adenocarcinoma 1 Platinum-resistant Recurrent Clear Cell Ovarian Cancer 1 Pancreatic Adenocarcinoma 1 Ovarian Diseases 1 Mesothelioma, Malignant 1 Melanoma 1 Leukemia, Prolymphocytic, T-Cell 1

Interventions

niraparib 1 cabozantinib 1 avelumab 1 Sunitinib 1 Paclitaxel 1 Gemcitabine 1 Everolimus 1 Cisplatin 1 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Urothelial Cancer × niraparib × Clear all

NCT03425201 2024-12-31

NICARAGUA

Fundacion CRIS de Investigación para Vencer el Cáncer

Phase 1/2 Completed

Urothelial Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡